US Stock MarketDetailed Quotes

KURA Kura Oncology

Watchlist
  • 9.010
  • +0.040+0.45%
Close Dec 20 16:00 ET
  • 9.174
  • +0.164+1.82%
Post 20:01 ET
700.65MMarket Cap-3.83P/E (TTM)

Kura Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
40.99%59.88M
41.00%56.4M
48.91%54.45M
18.55%165.8M
33.01%46.76M
16.07%42.47M
13.22%40M
11.54%36.57M
6.56%139.87M
6.41%35.16M
Selling and administrative expenses
38.30%18.18M
41.08%16.68M
59.87%18.18M
7.47%50.57M
13.94%14.23M
13.11%13.15M
6.74%11.82M
-4.17%11.37M
1.11%47.05M
3.36%12.49M
-General and administrative expense
38.30%18.18M
41.08%16.68M
59.87%18.18M
7.47%50.57M
13.94%14.23M
13.11%13.15M
6.74%11.82M
-4.17%11.37M
1.11%47.05M
3.36%12.49M
Research and development costs
42.20%41.71M
40.97%39.73M
43.97%36.27M
24.16%115.24M
43.52%32.53M
17.44%29.33M
16.18%28.18M
20.46%25.19M
9.55%92.81M
8.17%22.67M
Operating profit
-40.99%-59.88M
-41.00%-56.4M
-48.91%-54.45M
-18.55%-165.8M
-33.01%-46.76M
-16.07%-42.47M
-13.22%-40M
-11.54%-36.57M
-6.56%-139.87M
-6.41%-35.16M
Net non-operating interest income expense
41.57%5.48M
96.78%5.57M
97.32%4.93M
227.28%13.17M
94.71%3.98M
255.14%3.87M
401.60%2.83M
658.97%2.5M
408.21%4.03M
592.20%2.04M
Non-operating interest income
37.82%5.89M
85.73%5.97M
86.12%5.33M
246.07%14.72M
92.43%4.37M
292.20%4.28M
470.21%3.22M
769.60%2.86M
252.74%4.25M
669.83%2.27M
Non-operating interest expense
1.98%412K
4.91%406K
9.34%398K
576.42%1.55M
72.05%394K
--404K
--387K
--364K
-44.69%229K
--229K
Other net income (expense)
Income before tax
-40.94%-54.4M
-36.75%-50.84M
-45.37%-49.53M
-12.36%-152.63M
-29.21%-42.79M
-8.73%-38.6M
-6.92%-37.17M
-4.98%-34.07M
-4.12%-135.84M
-1.13%-33.11M
Income tax
Net income
-40.94%-54.4M
-36.75%-50.84M
-45.37%-49.53M
-12.36%-152.63M
-29.21%-42.79M
-8.73%-38.6M
-6.92%-37.17M
-4.98%-34.07M
-4.12%-135.84M
-1.13%-33.11M
Net income continuous Operations
-40.94%-54.4M
-36.75%-50.84M
-45.37%-49.53M
-12.36%-152.63M
-29.21%-42.79M
-8.73%-38.6M
-6.92%-37.17M
-4.98%-34.07M
-4.12%-135.84M
-1.13%-33.11M
Minority interest income
Net income attributable to the parent company
-40.94%-54.4M
-36.75%-50.84M
-45.37%-49.53M
-12.36%-152.63M
-29.21%-42.79M
-8.73%-38.6M
-6.92%-37.17M
-4.98%-34.07M
-4.12%-135.84M
-1.13%-33.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-40.94%-54.4M
-36.75%-50.84M
-45.37%-49.53M
-12.36%-152.63M
-29.21%-42.79M
-8.73%-38.6M
-6.92%-37.17M
-4.98%-34.07M
-4.12%-135.84M
-1.13%-33.11M
Basic earnings per share
-26.00%-0.63
-11.32%-0.59
-18.00%-0.59
-2.46%-2.08
-12.24%-0.55
5.66%-0.5
-1.92%-0.53
-2.04%-0.5
-3.05%-2.03
0.00%-0.49
Diluted earnings per share
-26.00%-0.63
-11.32%-0.59
-18.00%-0.59
-2.46%-2.08
-12.24%-0.55
5.66%-0.5
-1.92%-0.53
-2.04%-0.5
-3.05%-2.03
0.00%-0.49
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 40.99%59.88M41.00%56.4M48.91%54.45M18.55%165.8M33.01%46.76M16.07%42.47M13.22%40M11.54%36.57M6.56%139.87M6.41%35.16M
Selling and administrative expenses 38.30%18.18M41.08%16.68M59.87%18.18M7.47%50.57M13.94%14.23M13.11%13.15M6.74%11.82M-4.17%11.37M1.11%47.05M3.36%12.49M
-General and administrative expense 38.30%18.18M41.08%16.68M59.87%18.18M7.47%50.57M13.94%14.23M13.11%13.15M6.74%11.82M-4.17%11.37M1.11%47.05M3.36%12.49M
Research and development costs 42.20%41.71M40.97%39.73M43.97%36.27M24.16%115.24M43.52%32.53M17.44%29.33M16.18%28.18M20.46%25.19M9.55%92.81M8.17%22.67M
Operating profit -40.99%-59.88M-41.00%-56.4M-48.91%-54.45M-18.55%-165.8M-33.01%-46.76M-16.07%-42.47M-13.22%-40M-11.54%-36.57M-6.56%-139.87M-6.41%-35.16M
Net non-operating interest income expense 41.57%5.48M96.78%5.57M97.32%4.93M227.28%13.17M94.71%3.98M255.14%3.87M401.60%2.83M658.97%2.5M408.21%4.03M592.20%2.04M
Non-operating interest income 37.82%5.89M85.73%5.97M86.12%5.33M246.07%14.72M92.43%4.37M292.20%4.28M470.21%3.22M769.60%2.86M252.74%4.25M669.83%2.27M
Non-operating interest expense 1.98%412K4.91%406K9.34%398K576.42%1.55M72.05%394K--404K--387K--364K-44.69%229K--229K
Other net income (expense)
Income before tax -40.94%-54.4M-36.75%-50.84M-45.37%-49.53M-12.36%-152.63M-29.21%-42.79M-8.73%-38.6M-6.92%-37.17M-4.98%-34.07M-4.12%-135.84M-1.13%-33.11M
Income tax
Net income -40.94%-54.4M-36.75%-50.84M-45.37%-49.53M-12.36%-152.63M-29.21%-42.79M-8.73%-38.6M-6.92%-37.17M-4.98%-34.07M-4.12%-135.84M-1.13%-33.11M
Net income continuous Operations -40.94%-54.4M-36.75%-50.84M-45.37%-49.53M-12.36%-152.63M-29.21%-42.79M-8.73%-38.6M-6.92%-37.17M-4.98%-34.07M-4.12%-135.84M-1.13%-33.11M
Minority interest income
Net income attributable to the parent company -40.94%-54.4M-36.75%-50.84M-45.37%-49.53M-12.36%-152.63M-29.21%-42.79M-8.73%-38.6M-6.92%-37.17M-4.98%-34.07M-4.12%-135.84M-1.13%-33.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -40.94%-54.4M-36.75%-50.84M-45.37%-49.53M-12.36%-152.63M-29.21%-42.79M-8.73%-38.6M-6.92%-37.17M-4.98%-34.07M-4.12%-135.84M-1.13%-33.11M
Basic earnings per share -26.00%-0.63-11.32%-0.59-18.00%-0.59-2.46%-2.08-12.24%-0.555.66%-0.5-1.92%-0.53-2.04%-0.5-3.05%-2.030.00%-0.49
Diluted earnings per share -26.00%-0.63-11.32%-0.59-18.00%-0.59-2.46%-2.08-12.24%-0.555.66%-0.5-1.92%-0.53-2.04%-0.5-3.05%-2.030.00%-0.49
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data